Brief: Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market
30/07/2026 11:26
BRIEF-Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market July 30 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK:
INITIATES REGISTRATION AND LAUNCH PREPARATIONS FOR GAURUNNING IN NORTH AFRICAN MARKET
GAURUNNING RECEIVES MARKETING APPROVAL FROM CHINA'S NMPA ON MAY 15, 2025
Further company coverage: 1228.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CANbridge Pharmaceuticals
See all newsChina's CANbridge Pharmaceuticals H1 revenue rises on Hunterase and Livmarli strength
Brief: CANbridge Pharmaceuticals Posts HY Loss of RMB37.1 MLN
Brief: Canbridge Pharmaceuticals Says Livmarli Obtains NHIA Reimbursement Approval In Taiwan For ALGS And PFIC
Brief: Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market
CANbridge Pharmaceuticals jumps as WuXi Biologics buys shares